- $390.63m
- $521.43m
- $822.31m
Brief: Orthofix Medical Q2 Sales USD 187 Million
Orthofix Medical Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Orthofix Announces Changes To Board Of Directors
Brief: Orthofix Medical Enters Into Second Amended, Restated Credit Agreement
Orthofix Medical Inc reports results for the quarter ended in March - Earnings Summary
Brief: Orthofix Reports First Quarter 2023 Results
Orthofix Medical Inc expected to post a loss of 51 cents a share - Earnings Preview
Brief: Orthofix Medical Holds No Deposits Or Securities At SVB
Brief: Orthofix Medical Reports Orthofix And Seaspine Q4 And Full-Year 2022 Results
Orthofix Medical Inc reports results for the quarter ended in December - Earnings Summary
Brief: Orthofix Medical Q4 gross profit USD 89.176 million
Orthofix Medical Inc expected to post earnings of 34 cents a share - Earnings Preview
Orthofix Medical Inc expected to post earnings of 34cents a share - Earnings Preview
Brief: Orthofix To Full Commercial Launch, First Patient Cases Of Mariner Deformity System
Brief: Orthofix Medical Inc - On January 3, 2023, Appointed Keith C. Valentine As Orthofix’S President And Chief Executive Officer
Brief: Orthofix And Seaspine Announce Completion Of Merger
Brief: Orthofix Publishes Data Demonstrating Clinical Benefits Of Trinity Elite CBA
Orthofix Medical gains on unsolicited acquisition offer
Brief: Seaspine- Orthofix Received Indication Of Interest From Two Private Equity Fund Sponsors To Acquire Outstanding Equity For $23.00/ Share In Cash